Helmut Schumacher

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

Johannes F.E. Mann, Roland E. Schmieder, Matthew McQueen et al. · The Lancet · 2008 · 1.6K citations

Hypertension, Urology, Renal Disease +12

Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial

Silke Walter, Panagiotis Kostopoulos, Isabel Keller et al. · The Lancet Neurology · 2012 · 484 citations

Thrombosis, Stroke Rehabilitation, Cardiovascular Disease +12

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials

Koon Teo, Salim Yusuf, Peter Sleight et al. · American Heart Journal · 2004 · 382 citations

Thrombosis, Hypertension, Ongoing Telmisartan Alone +11

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

Peter Sleight, Josep Redón, Paolo Verdecchia et al. · Journal of Hypertension · 2009 · 351 citations · Full text

Perioperative Acute Ischemic Stroke in Noncardiac and Nonvascular Surgery

Brian T. Bateman, Helmut Schumacher, Shuang Wang et al. · Anesthesiology · 2009 · 295 citations · Full text